We are a preclinical-stage biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. An irreversible small molecule drug is a synthetic compound that forms a permanent bond to its target protein and offers a number of potential advantages over conventional reversible drugs, including […]

We are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Our mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology […]

We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System that combines an advanced infrastructure layer to generate what we believe is […]

“We co-invented a COVID-19 vaccine candidate with the University of Oxford, which we assigned to Oxford University Innovation, or OUI, to facilitate the license of those rights by OUI to AstraZeneca UK Limited, or AstraZeneca. This vaccine is now known as COVID-19 Vaccine AstraZeneca, which we refer to as AZD1222. AstraZeneca has exclusive worldwide rights […]

Our initial strategy is to identify a business combination target within the Middle East, North Africa (“MENA”) or South & Southeast Asia regions. Although we are not limited to any specific industry, we intend to focus on business combination targets within industries with relatively secure and predictable cash flows and growth. Our strategic partner, Innvotec Limited […]

(Note: This blank-check company or SPAC offering consists of Class A ordinary shares. This is NOT a unit offering, which is typical for blank-check or SPAC IPOs. TPG Pace Solutions Corp. – proposed symbol TPGS – is incorporated in the Cayman Islands. TPG, the private equity behemoth, has a significant ownership interest in the sponsor […]

Based in Berlin, Tio Tech A will focus on tech-enabled businesses in Europe. (Blank-check company or SPAC Incorporated in the Cayman Islands) Dominik Richter, the chairman of our board, is the founder and CEO of HelloFresh SE, a Frankfurt-listed e-commerce food solutions company with a market cap of more than $10 billion as of Dec. […]

It is our intention to pursue prospective targets that are in Asia. We will primarily seek to acquire one or more growth businesses with a total enterprise value of between $200 million and $600 million. (Incorporated in the British Virgin Islands)  Mr. Claudius Tsang, our CEO and chairman, has over 20 years of experience in […]

We are a rapidly growing specialty distributor and select manufacturer of environmentally friendly disposable foodservice products and related items. We are a nimble supplier of a wide range of products for the foodservice industry, including food and take-out containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, equipment, gloves and other products. Our products […]

LumiraDx was founded in 2014 by a group of entrepreneurs – Ron Zwanziger, our chairman and CEO; Dave Scott Ph.D., our chief technology officer, and Jerry McAleer, Ph.D., our chief scientist, who have a successful track record in building and scaling diagnostics and health IT businesses over three decades. (LumiraDx was incorporated in 2016 in […]